Literature DB >> 3109793

Renal histological lesions and clinical syndromes in multiple myeloma. Renal Immunopathology Group.

S Pasquali, P Zucchelli, S Casanova, L Cagnoli, R Confalonieri, C Pozzi, G Banfi, A Lupo, T Bertani.   

Abstract

This retrospective multicenter study, based on 42 patients affected by renal damage due to multiple myeloma, analyzes the renal biopsy results, the clinical data at the time of biopsy and the subsequent renal outcome in order to clarify the correlations existing between clinical and histological changes. Plasmocytoma components were Bence Jones alone in 55% of the patients and light-chain excretion was present in over 90%. Rapidly progressive renal failure was the most frequent clinical presentation (27 cases). The histological lesions directly attributable to multiple myeloma were subdivided into 3 basic categories: related to light-chains, direct tumor involvement of renal parenchyma and attributable to systemic effects of neoplastic disease. Light-chains seemed to cause renal lesions in 59.4% of the cases. Myeloma cast nephropathy was the prominent bioptic diagnosis established (20 cases). Among the clinical, laboratory and histological parameters studied, only the degree of tubular-interstitial damage was significantly correlated to the renal outcome in the 32 patients who had an adequately documented follow-up period.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3109793

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  7 in total

Review 1.  Myeloma light chain cast nephropathy, a review.

Authors:  Insara Jaffer Sathick; Maria Eleni Drosou; Nelson Leung
Journal:  J Nephrol       Date:  2018-05-05       Impact factor: 3.902

2.  Renal failure caused by plasma cell infiltration in multiple myeloma.

Authors:  Shiho Hanawa; Tetsu Akimoto; Eisuke Uehara; Makoto Inoue; Toshimi Imai; Atsushi Kotoda; Hiromichi Yoshizawa; Tomohiro Matsuyama; Masuzu Ueda; Osamu Saito; Yoshitomo Hamano; Wako Yumura; Keiya Ozawa; Shigeaki Muto; Eiji Kusano
Journal:  Clin Exp Nephrol       Date:  2011-03-25       Impact factor: 2.801

3.  Renal tubular lesions induced by human Bence Jones protein in the rat: N-acetyl-beta-D-glucosaminidase as a sensitive marker.

Authors:  N Yokota; Y Yamamoto; K Kitamura; N Kuroki; S Hisanaga; S Fujimoto; T Eto; K Tanaka
Journal:  Int J Exp Pathol       Date:  1991-06       Impact factor: 1.925

4.  Recent advances in the pathogenesis and management of cast nephropathy (myeloma kidney).

Authors:  Stephanie Stringer; Kolitha Basnayake; Colin Hutchison; Paul Cockwell
Journal:  Bone Marrow Res       Date:  2011-05-04

5.  Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study.

Authors:  Virginie Royal; Nelson Leung; Stéphan Troyanov; Samih H Nasr; Laure Écotière; Richard LeBlanc; Benjamin A Adam; Andrea Angioi; Mariam P Alexander; Anna Maria Asunis; Antonella Barreca; Paola Bianco; Camille Cohen; Maria E Drosou; Huma Fatima; Roberta Fenoglio; François Gougeon; Jean-Michel Goujon; Guillermo A Herrera; Bertrand Knebelmann; Nicola Lepori; Francesca Maletta; Rita Manso; Shveta S Motwani; Antonello Pani; Marion Rabant; Helmut G Rennke; Dario Rocatello; Frida Rosenblum; Paul W Sanders; Afonso Santos; Karina Soto; Banu Sis; Guy Touchard; Christopher P Venner; Frank Bridoux
Journal:  Blood       Date:  2020-05-21       Impact factor: 25.476

Review 6.  The pathogenesis of renal injury and treatment in light chain deposition disease.

Authors:  Qi Wang; Fang Jiang; Gaosi Xu
Journal:  J Transl Med       Date:  2019-11-25       Impact factor: 5.531

7.  Plasma Cell Infiltration of the Kidney as a Manifestation of Myeloma: A Report of Three Cases.

Authors:  T Kaur; S Krishnaprasad; R Shankar; R Kumar; S Gowrishankar; M D Padua
Journal:  Indian J Nephrol       Date:  2017 Sep-Oct
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.